Highlights of some of our recent deals in this sector.
Up to £20m
| Advised Velleoats, a Russian company that developed and sells a range of fermented oat-based nutritional products. |
£20m- £100m
| Advised long-standing client Synova Capital on its significant minority growth investment into Preventx. Read more > | Advised the shareholders of Argint International on the disposal of the group to Precision Medicine Group. Read more > | Advised Takeda on its investment in, and option to acquire, Adaptate Biotherapeutics, a biotechnology company spun-out of GammaDelta Therapeutics. |
| Advised on a secondary placing and open offer for Creo Medical Group plc. Read more > |
£100m+
| Advised Universal Health Services on its acquisition of Cambian Group’s Adult Services Division (£377m). Read more > | Advised the management team of a property holding company, backed by a portfolio of investors led by Centerbridge Partners, on the sale of its real estate assets to Medical Properties Trust (US$2bn). Read more > |
